This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 Dec 9;356(9246):2009-10.

doi: 10.1016/S0140-6736(05)72978-0.

Alosetron for irritable bowel syndrome

E Barbehenn, P Lurie, S M Wolfe

PMID: 11130544
DOI: 10.1016/S0140-6736(05)72978-0

Comment

Alosetron for irritable bowel syndrome

E Barbehenn et al. Lancet. 2000.

. 2000 Dec 9;356(9246):2009-10.

doi: 10.1016/S0140-6736(05)72978-0.

Authors

E Barbehenn, P Lurie, S M Wolfe

PMID: 11130544
DOI: 10.1016/S0140-6736(05)72978-0

No abstract available

PubMed Disclaimer

Comment on

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial.
Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW. Camilleri M, et al. Lancet. 2000 Mar 25;355(9209):1035-40. doi: 10.1016/S0140-6736(00)02033-X. Lancet. 2000. PMID: 10744088 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information